AR110236A1 - Conjugados de vmen-antígeno y uso de los mismos - Google Patents
Conjugados de vmen-antígeno y uso de los mismosInfo
- Publication number
- AR110236A1 AR110236A1 ARP170103286A ARP170103286A AR110236A1 AR 110236 A1 AR110236 A1 AR 110236A1 AR P170103286 A ARP170103286 A AR P170103286A AR P170103286 A ARP170103286 A AR P170103286A AR 110236 A1 AR110236 A1 AR 110236A1
- Authority
- AR
- Argentina
- Prior art keywords
- vmen
- conjugates
- antigen
- same
- immunization
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/075—Adenoviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La tecnología propuesta se encuentra en el ámbito de la conjugación de vesículas de membrana externa nativas (VMEn), extraídas sin detergente, con antígenos para formar conjugados de VMEn-enlazador-antígeno, que son particularmente útiles para composiciones inmunogénicas e inmunización; también se proporcionan procedimientos para la preparación y el uso de tales conjugados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1619949.9A GB201619949D0 (en) | 2016-11-25 | 2016-11-25 | nOMV-antigen conjugated compounds and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR110236A1 true AR110236A1 (es) | 2019-03-06 |
Family
ID=58073117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170103286A AR110236A1 (es) | 2016-11-25 | 2017-11-24 | Conjugados de vmen-antígeno y uso de los mismos |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR110236A1 (es) |
| GB (1) | GB201619949D0 (es) |
-
2016
- 2016-11-25 GB GBGB1619949.9A patent/GB201619949D0/en not_active Ceased
-
2017
- 2017-11-24 AR ARP170103286A patent/AR110236A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201619949D0 (en) | 2017-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019010625A2 (pt) | conjugado imunogênico, processo para preparar o conjugado imunogênico, nomv-ligante intermediário, usos do mesmo e de nomv, composição imunogênica, e, vacina. | |
| MX2022014980A (es) | Conjugados de polipeptido-antigeno con aminoacidos no naturales. | |
| BR112018004242A2 (pt) | composições de vacina que possuem estabilidade e imunogenicidade aumentadas | |
| BR112019010227A2 (pt) | conjugado imunogênico, processo para preparação de conjugado imunogênico, composição imunogênica, vacina, e, uso de nomv | |
| CO2019014677A2 (es) | Vectores de poxvirus que codifican antígenos del virus de inmunodeficiencia humana (vih), y métodos de uso de los mismos | |
| CL2018002792A1 (es) | Receptores quiméricos de flt3 y métodos de uso de los mismos. | |
| MX2019004690A (es) | Constructos de anticuerpos. | |
| CL2015002157A1 (es) | Una composición inmunogenica que comprende: un sacárido capsular pneumococico conjugado, incluyendo sacarido depolimerizado de serotipo 18c; y antígeno de proteína de unión a factor h (fhbp) menincocócico, pero sin incluir vesículas de membrana meningocócica; metodo de preparación de la composición | |
| MX2017003268A (es) | Anticuerpos de un solo dominio dirigidos contra antigenos intracelulares. | |
| AR130778A2 (es) | Vacunas de meningococos | |
| AR076106A1 (es) | Anticuerpos anti-cd40 y usos de los mismos | |
| MX2018015361A (es) | Formulacion de vacuna contra el vih. | |
| UY36006A (es) | Construcciones de proteína uspa2 y usos de las mismas. | |
| BR112015009070A2 (pt) | proteína de fusão ou coquetel de antígenos; uso de uma proteína de fusão ou um coquetel de antígenos; vacina; e método para imunizar um animal, que inclui um ser humano, contra tuberculose causada por microbactérias virulentas | |
| CL2016002142A1 (es) | Proteínas de fusión tatk-cdkl5, composiciones, formulaciones y uso de estas | |
| ECSP18081582A (es) | Constructos de alfavirus vivo atenuado y métodos y usos de los mismos | |
| CL2019000655A1 (es) | Nuevo sitio de inserción orf70 de ehv. | |
| CO2021012294A2 (es) | Composiciones de lawsonia intracellularis y métodos de uso de las mismas | |
| CL2019000705A1 (es) | Nuevos promotores. | |
| EA201991319A1 (ru) | Вакцины аттенуированного свиного гриппа и способы их изготовления и применения | |
| AR110236A1 (es) | Conjugados de vmen-antígeno y uso de los mismos | |
| PE20160174A1 (es) | Composiciones vacunales bivalentes y su uso para la terapia de tumores | |
| CL2018000155A1 (es) | Composiciones de adyuvante liposomal | |
| CL2022000086A1 (es) | Vacunas contra ehrlichia y composiciones inmunogénicas | |
| AR088908A1 (es) | Vacuna |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |